Series A funding round for Rgenta Therapeutics raising $52M in November 2022
Series A funding round for Rgenta Therapeutics raising $52M in November 2022
| Investor | Firm Type | Partner |
|---|
AstraZeneca R&DLEAD | Private | — |
| Venture Capital | — |
| Venture Capital | — |
| Corporate Venture Capital | — |
| Venture Capital | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$90M
Top Valuation
-
Rgenta Therapeutics raised $52M in a Series A round.
The round was announced on 11/01/22.
The round was led by Chen Bing.